Gene Therapy 15-Year Follow-Up In Four AE Categories Suggested By Cmte.
Executive Summary
Gene therapy clinical trial subjects should be followed in four adverse event categories for 15 years, FDA's Biological Response Modifiers Advisory Committee recommended Oct. 24.